ASO Visual Abstract: Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer

被引:0
|
作者
Lisa Frankinet
Aditi Bhatt
Vincent Alcazer
Jean-Marc Classe
Jean-Marc Bereder
Pierre Meeus
Christophe Pomel
Francois Mithieux
Karine Abboud
Romauld Wermert
Vincent Lavoue
Frederic Marchal
Olivier Glehen
Naoual Bakrin
机构
[1] Centre Hospitalier Lyon Sud,Department of General Surgery, Hospices Civils de Lyon
[2] Zydus Hospital,Department of Surgical Oncology
[3] Centre Hospitalier Lyon-sud,Department of Medical Oncology
[4] Centre René Gauducheau,Department of Surgical Oncology
[5] Centre Hospitalier L’Archet,Department of Surgical Oncology
[6] Centre Léon Bérard,Department of Surgical Oncology
[7] Centre Jean Perrin,Department of Surgical Oncology
[8] Hopital Privé Jean Mermoz,Department of Surgical Oncology
[9] Hopital Nord St Etienne,Deptartment of Surgical Oncology
[10] Centre Paul Papin,Department of Surgical Oncology
[11] Centre Hospitralo-Universitaire Rennes,Department of Surgical Oncology
[12] Université de Lorraine,Department of Surgical Oncology, Institut de Cancérologir de Lorraine Alexis Vautrin
[13] Lyon 1 University,CICLY
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3302 / 3303
页数:1
相关论文
共 50 条
  • [31] Re: "Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.
    Ansaloni, Luca
    De Iaco, Pierandrea
    Frigerio, Luigi
    GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 279 - 281
  • [32] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: Upfront therapy, at first recurrence, or later?
    Gonzalez Bayon, L.
    Steiner, M. A.
    Vasquez Jimenez, W.
    Asencio, J. M.
    Alvarez de Sierra, P.
    Atahualpa Arenas, F.
    Rodriguez del Campo, J.
    Garcia Sabrido, J. L.
    EJSO, 2013, 39 (10): : 1109 - 1115
  • [33] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: Upfront therapy, first recurrence or later?
    Steiner, M.
    Gonzalez Bayon, L.
    Vasquez, W.
    Asencio, J.
    Alvarez de Sierra, P.
    Atahualpa, F.
    Garcia Sabrido, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S722 - S723
  • [34] ASO Visual Abstract: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study
    Trecourt, Alexis
    Bakrin, Naoual
    Glehen, Olivier
    Gertych, Witold
    Villeneuve, Laurent
    Isaac, Sylvie
    Benzerdjeb, Nazim
    Fontaine, Juliette
    Genestie, Catherine
    Dartigues, Peggy
    Leroux, Agnes
    Quenet, Francois
    Marchal, Frederic
    Odin, Cecile
    Khellaf, Lakhdar
    Svrcek, Magali
    Thierry, Sixte
    Augros, Marilyn
    Omar, Alhadeedi
    Devouassoux-Shisheboran, Mojgan
    Kepenekian, Vahan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 3361 - 3363
  • [35] Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
    Yarema, Roman
    Volodko, Nataliya
    Fetsych, Taras
    Ohorchak, Myron
    Petronchak, Orest
    Mylyan, Yuriy
    Makukh, Halyna
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2019, 32 (03) : 154 - 159
  • [36] ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?
    Mangieri, Christopher W.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3694 - 3694
  • [37] Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
    Lei, Ziying
    Wang, Yue
    Wang, Jiahong
    Wang, Ke
    Tian, Jun
    Zhao, Ying
    Chen, Lipai
    Wang, Jin
    Luo, Jiali
    Jia, Manman
    Tang, Hongsheng
    He, Qingjun
    Liao, Quanxing
    Yang, Xiansheng
    Guan, Tianpei
    Wang, Li
    Cui, Shuzhong
    JAMA NETWORK OPEN, 2020, 3 (08) : E2013940
  • [38] ASO Visual Abstract: Restrictive Intraoperative Fluid Rate Is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Peng, June S.
    LaPiano, Jessica
    Wang, Katy
    Attwood, Kristopher
    Skitzki, Joseph J.
    Kane, John M., III
    Francescutti, Valerie A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 638 - 639
  • [39] ASO Visual Abstract: Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Hanna, David N.
    Ghani, Muhammad O.
    Hermina, Andrew
    Mina, Alexander
    Bailey, Christina E.
    Idrees, Kamran
    Magge, Deepa
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 685 - 686
  • [40] ASO Visual Abstract: Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    David N. Hanna
    Muhammad O. Ghani
    Andrew Hermina
    Alexander Mina
    Christina E. Bailey
    Kamran Idrees
    Deepa Magge
    Annals of Surgical Oncology, 2021, 28 : 685 - 686